We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Immunoturbidimetric Test for D-Dimer Performed on Clinical Chemistry Systems

By LabMedica International staff writers
Posted on 05 May 2009
A newly designed particle-enhanced immunoturbidimetric test for D-Dimer is designed for use on automated clinical chemistry systems. More...
D-Dimer tests are used for exclusion of deep vein thrombosis (DVT) of the leg.

The new D-Dimer FS immunoturbidimetric test has a cut-off value of 0.5 µg FEU/ml (fibrinogen equivalent units per milliliter) and shows good diagnostic sensitivity ensuring that 98 % of patients with DVT are found true-positive. The two-component reagent is liquid-stable and ready to use. The test covers a wide measuring range up to 8.7 µg FEU/ml and stands out for its high prozone security up to 50 µg FEU/ml. D-Dimer FS shows excellent calibration and on-board stability up to six weeks.

D-Dimer FS is a product of DiaSys Diagnostic Systems (Holzheim, Germany), a company that develops, manufactures, and distributes a full range of diagnostic reagents for clinical chemistry and including controls and calibrators. The company focuses on liquid-stable, ready-to-use reagents for measurement of enzymes and substrates, and immunoturbidimetric tests for the measurement of specific proteins.

The company's current product range lists more than 80 reagents in convenient packages for routine and special diagnostics on photometers or automated analyzers. The product range is completed by clinical chemistry analyzers and point-of-care instruments for diabetes monitoring.

Related Links:

DiaSys Diagnostic Systems





New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Immunofluorescence Analyzer
IFA System
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.